Galmed Pharmaceuticals
GLMD
#10465
Rank
NZ$6.46 M
Marketcap
NZ$1.18
Share price
-5.33%
Change (1 day)
-75.67%
Change (1 year)

Market capitalization of Galmed Pharmaceuticals (GLMD)

Market cap: NZ$6.46 Million

As of February 2026 Galmed Pharmaceuticals has a market cap of NZ$6.46 Million. This makes Galmed Pharmaceuticals the world's 10465th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galmed Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$6.46 M-21.05%
2025NZ$8.18 M-10.72%
2024NZ$9.16 M217.98%
2023NZ$2.88 M-85.48%
2022NZ$19.84 M-70.3%
2021NZ$66.83 M-27.24%
2020NZ$91.85 M-49.37%
2019NZ$0.18 B-15.23%
2018NZ$0.21 B21.07%
2017NZ$0.17 B187.14%
2016NZ$61.56 M-50.12%
2015NZ$0.12 B50.2%
2014NZ$82.17 M

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Galmed Pharmaceuticals was reported to be:

NZ$6.46 Million
by Nasdaq info icon info icon
NZ$6.46 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Evoke Pharma
EVOK
NZ$31.47 M 387.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
NZ$0.23 M-96.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
NZ$1.25 B 19,271.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
NZ$19.13 B 296,085.85%๐Ÿ‡บ๐Ÿ‡ธ USA